BeiGene, Ltd. (BEIGF)
OTCMKTS
· Delayed Price · Currency is USD
15.50
0.00 (0.00%)
At close: Nov 11, 2024
BeiGene Market Cap
BeiGene has a market cap or net worth of $20.64 billion as of November 21, 2024. Its market cap has increased by 1.08% in one year.
Market Cap
20.64B
Enterprise Value
18.98B
Revenue
3.35B
Ranking
n/a
PE Ratio
n/a
Stock Price
$15.50
Market Cap Chart
Since February 3, 2016, BeiGene's market cap has increased from 858.74M to 20.64B, an increase of 2,303.44%. That is a compound annual growth rate of 43.52%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sandoz Group AG | 19.75B |
Telix Pharmaceuticals Limited | 5.00B |
Elekta AB (publ) | 2.20B |
Ryman Healthcare Limited | 1.97B |
Verano Holdings Corp. | 608.31M |
Vireo Growth Inc. | 109.11M |
Medexus Pharmaceuticals Inc. | 39.31M |